Stage IV Surgery Versus Best Medical Therapy
Public ClinicalTrials.gov record NCT01013623. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized Trial of Surgical Resection With or Without BCG Versus Best Medical Therapy as Initial Treatment in Stage IV Melanoma
Study identification
- NCT ID
- NCT01013623
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Saint John's Cancer Institute
- Other
- Enrollment
- 12 participants
Conditions and interventions
Conditions
Interventions
- Surgery Procedure
- Surgery plus 2 adjuvant doses of BCG Procedure
- best medical therapy Other
Procedure · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2009
- Primary completion
- Aug 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Sep 25, 2012
2009 – 2012
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Davis Medical Center | Sacramento | California | 95817 | — |
| John Wayne Cancer Institute | Santa Monica | California | 90404 | — |
| Rush University | Chicago | Illinois | 60612 | — |
| Mayo Clinic Cancer Center | Rochester | Minnesota | 55905 | — |
| Buffalo General Hospital | Buffalo | New York | 14203 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Penn State Hershey Cancer Center | Hershey | Pennsylvania | 17033 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Geisinger Clinic | Wilkes-Barre | Pennsylvania | 18711 | — |
| Main Line Health System | Wynnewood | Pennsylvania | 19096 | — |
| Dallas Surgical Group | Dallas | Texas | 75235 | — |
| UT Southwestern Medical Center at Dallas | Dallas | Texas | 75390-9155 | — |
| IHC Cancer Services Intermountain Healthcare | Murray | Utah | 84157 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01013623, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01013623 live on ClinicalTrials.gov.